Author Question: In severe cases of pneumothorax, the mediastinum and trachea: a. remain midline. b. sink ... (Read 50 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
In severe cases of pneumothorax, the mediastinum and trachea:
 
  a. remain midline.
  b. sink posteriorly into the chest cavity.
  c. are shifted toward from the side with the pneumothorax.
  d. are shifted away from the side with the pneumothorax.

Question 2

In which mode does flow asynchrony most commonly occur?
 
  a. Volume ventilation.
  b. Pressure ventilation.
  c. CPAP.
  d. No mode is more susceptible.



mtmmmmmk

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

ANS: D
As pressure increases, the affected side's lung collapses and begins to compress the unaffected side. In severe cases, the mediastinum and trachea are shifted away from the side with the pneumothorax.

Answer to Question 2

ANS: A
Flow asynchrony occurs when the flow from the ventilator does not match the flow demand of the patient. This can occur in any mode of ventilation but most commonly occurs in volume ven-tilation because the clinician sets the tidal volume, peak flow, flow waveform, and inspiratory time.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library